Welcome to the official BENLYSTA account.
Community Guidelines: https://gsk.to/42csfAD
Prescribing Information: https://gskp.ro/4djxthw
Intended for US healthcare professionals only.
Trademarks are owned by or licensed to the GSK group of companies.
©2024 GSK or licensor.
PMUS-BELSMP240078 October 2024
Produced in USA.
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://BENLYSTAhcp.com
- Competitors
- Entyvio (vedolizumab), KEYTRUDA® (pembrolizumab) HCP, NUCALA (mepolizumab), QUVIVIQ® (daridorexant), ZERBAXA® (ceftolozane and tazobactam) HCP, OPDIVO® (nivolumab) US HCP, PLUVICTO® (lutetium Lu 177 vipivotide tetraxetan) HCP, LUMAKRAS® (sotorasib) HCP, TEZSPIRE® (tezepelumab-ekko) HCP, TAGRISSO® (osimertinib) HCP.
Benlysta (Belimumab) Questions
Benlysta (Belimumab)'s website is http://BENLYSTAhcp.com
Benlysta (Belimumab)'s LinkedIn profile is https://www.linkedin.com/company/benlystahcp
Benlysta (Belimumab)'s industry is
Pharmaceutical Manufacturing
Benlysta (Belimumab)'s top competitors are
Entyvio (Vedolizumab),
Keytruda® (Pembrolizumab) Hcp,
Nucala (Mepolizumab),
Quviviq® (Daridorexant),
Zerbaxa® (Ceftolozane And Tazobactam) Hcp,
Opdivo® (Nivolumab) Us Hcp,
Pluvicto® (Lutetium Lu 177 Vipivotide Tetraxetan) Hcp,
Lumakras® (Sotorasib) Hcp,
Tezspire® (Tezepelumab-Ekko) Hcp,
Tagrisso® (Osimertinib) Hcp.
Benlysta (Belimumab)'s categories are Pharmaceutical Manufacturing
